Subchronic administration of GABAergic agonists elevates [3H]GABA binding and produces tolerance in striatal dopamine catabolism
- 27 May 1985
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 335 (1) , 169-173
- https://doi.org/10.1016/0006-8993(85)90290-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- THIP analgesia: Cross tolerance with morphineLife Sciences, 1983
- The potential use of GABA agonists in psychiatric disorders: Evidence from studies with progabide in animal models and clinical trials1Pharmacology Biochemistry and Behavior, 1983
- Rate-controlled drug delivery: pharmacological, therapeutic and industrial perspectivesTrends in Pharmacological Sciences, 1982
- Interaction of striatal dopaminergic, cholinergic and GABA-ergic neurons: relation to extrapyramidal functionTrends in Pharmacological Sciences, 1980
- Interaction between GABA agonists and the cholinergic muscarinic system in rat corpus striatumLife Sciences, 1980
- γ‐VINYL GABA (4‐amino‐hex‐5‐enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA‐T: EFFECTS ON BRAIN GABA METABOLISM IN MICE1Journal of Neurochemistry, 1977
- THE EFFECT OF 4‐AMINO HEX‐5‐YNOIC ACID (γ‐ACETYLENIC GABA, γ‐ETHYNYL GABA) A CATALYTIC INHIBITOR OF GABA TRANSAMINASE, ON BRAIN GABA METABOLISM IN VIVOJournal of Neurochemistry, 1977
- HUNTINGTON'S CHOREABrain, 1974
- L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa TherapyNature, 1973
- THE ROLE OF GABA METABOLISM IN THE CONVULSANT AND ANTICONVULSANT ACTIONS OF AMINOOXYACETIC ACIDJournal of Neurochemistry, 1973